| Literature DB >> 33946466 |
Ting Shi1, Li Zheng2,3, Xiang-Qian Li1,4, Jia-Jia Dai1, Yi-Ting Zhang1, Yan-Yan Yu1, Wen-Peng Hu1, Da-Yong Shi1,4.
Abstract
The species Pseudogymnoascus is known as a psychrophilic pathogenic fungus which is ubiquitously distributed in Antarctica. While the studies of its secondary metabolites are infrequent. Systematic research of the metabolites of the Antarctic fungus Pseudogymnoascus sp. HSX2#-11 led to the isolation of one new pyridine derivative, 4-(2-methoxycarbonyl-ethyl)-pyridine-2-carboxylic acid methyl ester (1), together with one pyrimidine, thymine (2), and eight diketopiperazines, cyclo-(dehydroAla-l-Val) (3), cyclo-(dehydroAla-l-Ile) (4), cyclo-(dehydroAla-l-Leu) (5), cyclo-(dehydroAla-l-Phe) (6), cyclo-(l-Val-l-Phe) (7), cyclo-(l-Leu-l-Phe) (8), cyclo-(l-Trp-l-Ile) (9) and cyclo-(l-Trp-l-Phe) (10). The structures of these compounds were established by extensive spectroscopic investigation, as well as by detailed comparison with literature data. This is the first report to discover pyridine, pyrimidine and diketopiperazines from the genus of Pseudogymnoascus.Entities:
Keywords: Antarctic fungus; Pseudogymnoascus sp.; nitrogenous compounds; secondary metabolites
Mesh:
Substances:
Year: 2021 PMID: 33946466 PMCID: PMC8124204 DOI: 10.3390/molecules26092636
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds 1–10.
NMR spectroscopic data (600/150 MHz) for compounds 1 and 4.
| No. | 1 | 4 | ||||
|---|---|---|---|---|---|---|
| Pos | ||||||
| 1 | - | - | - | - | - | 10.53, s |
| 2 | 147.6, C | - | 147.5, C | - | 134.7, C | - |
| 3 | 125.4, CH | 8.00, br s | 124.9, CH | 7.94, dd (1.7, 0.8) | 158.6, C | - |
| 4 | 151.8, C | - | 151.1, C | - | - | 8.34, br s |
| 5 | 127.4, CH | 7.37, br s | 127.2, CH | 7.52, dd (5.0, 1.7) | 59.6, CH | 3.91, t (2.8) |
| 6 | 149.6, CH | 8.66, br s | 149.7, CH | 8.59, dd (5.0, 0.8) | 165.4, C | - |
| 7 | 165.4, C | - | 165.3, C | - | 40.7, CH | 1.85–1.80, m |
| 8 | 53.1, CH3 | 3.98, s | 52.4, CH3 | 3.87, s | 24.1, CH2 | 1.41–1.33, m |
| - | - | - | - | - | 1.20–1.12, m | |
| 9 | 30.1, CH2 | 3.03, t (7.5) | 29.2, CH2 | 2.95, t (7.5) | 11.7, CH3 | 0.85, t (7.4) |
| 10 | 34.0, CH2 | 2.69, t (7.5) | 33.2, CH2 | 2.73, t (7.5) | 14.8, CH3 | 0.88, d (7.0) |
| 11 | 172.4, C | - | 172.3, C | - | 98.8, CH2 | 5.17, br s |
| - | - | - | - | - | 4.76, br s | |
| 12 | 52.0, CH3 | 3.66, s | 51.4, CH3 | 3.58, s | - | - |
a measured in CDCl3, b measured in DMSO-d6.
Figure 2COSY (red bold line) and key HMBC (blue arrows) correlations of 1 and 4.
Specific OR of diketopiperazines 3–10 in CH3OH.
| Compounds | Natural [α] | Literature |
|---|---|---|
| 3 | −10.5 ( | [α |
| 4 | −19.3 ( | - |
| 5 | −78.1 ( | [α |
| 6 | −41.3 ( | [α |
| 7 | −25.3 ( | [α |
| 8 | +18.9 ( | [α |
| 9 | −16.5 ( | [α |
| 10 | −144.2 ( | [α |
a measured in DMSO.